Once again, Siemens sets the standard delivering a PET/CT system that stands apart from the rest. Embrace the future with the Biograph Trinion™5 featuring myExam Companion™ a system designed to keep you ahead of the curve while effortlessly adapting to your evolving clinical needs. the Biograph Trinion™5 with myExam Companion™.
The Biograph Trinion PET/CT combines top-tier hardware and software to deliver a powerful, unified platform. Its cutting-edge imaging experience enhances patient comfort, while its sleek design and AI-powered workflow boost user efficiency. Designed for flexibility, the Biograph Trinion ensures a smart, sustainable investment for the long term, with reduced costs thanks to its compact design, energy-saving automation, and scalability options.
While the growing clinical demand for Oncology, Cardiology and Neurology are on the rise, Siemens Trinion PET/CT is well prepared for the future with a scalable PET/CT system that can exceed the average scanner lifecycle and allow healthcare providers to expand patient access to more imaging services now and for the next generation.
Graph courtesy of Siemens Healthineers
High performance platform PET/CT imaging with the speed and precision that results from one platform that fully integrates best-in-class trio of PET, CT and syngo.via software⁶.
An innovative LSO-based digital detector, built in scalability next level CT, and integrated intelligent imaging capabilities, Biograph Trinion helps you step confidently into the future.
Full patient scan once took 20 minutes, now under 10 minutes and a 50% dose reduction.
- Fast imaging and low dose across all isotopes
- Consistent quality with ultra-fast time of flight (TOF)
- Reproductible results for every patient with FlowMotion AI
The future of PET/CT imaging is set for substantial growth, driven by various factors advancing healthcare and medical imaging technology. Several key elements point to this expected increase in PET/CT imaging:
- Rising Cancer Rates: With the global increase in cancer cases, the demand for precise and early detection through imaging technologies like PET/CT is set to grow. PET/CT plays a critical role in oncology, aiding staging, treatment planning, and monitoring therapeutic responses, all of which will drive its continued expansion.
- Aging Population: The growing number of elderly individuals worldwide is a significant factor fueling the demand for PET/CT scans. Older adults are more susceptible to conditions such as cancer, neurological disorders (e.g., Alzheimer’s disease), and cardiovascular diseases, all of which can be effectively diagnosed and tracked with PET/CT imaging.
- Technological Advancements: The integration of artificial intelligence, machine learning, and advanced algorithms into PET/CT scanners will significantly enhance their functionality, improving image quality, reducing scan durations, and boosting efficiency. Innovations like Time-of-Flight (TOF) PET, faster detectors, and hybrid imaging will further accelerate the adoption of PET/CT systems.
- Growth in Neurology and Cardiology: PET/CT is increasingly being utilized for diagnosing and managing neurological conditions (such as Alzheimer’s disease) and cardiovascular diseases. As ongoing research continues to highlight the advantages of PET/CT in these fields, its application in neurology and cardiology is expected to expand.
- Expanding Healthcare Access: As healthcare infrastructure continues to improve, especially in developing regions, more hospitals and imaging centers are likely to adopt PET/CT technologies. This expanded access to advanced imaging will lead to broader use among a wider range of patients.
- Government Support and Healthcare Investments: Governments and healthcare organizations are increasingly investing in advanced medical technologies like PET/CT scanners as part of their efforts to enhance healthcare outcomes, support early detection, and reduce long-term treatment costs. These investments will help drive the wider adoption of PET/CT imaging.
Graph courtesy of Siemens Healthineers
Clinical Impact
Thanks to its ultra-fast TOF⁴, the Biograph Trinion PET/CT lets you customize scan times and use any radiotracer. FlowMotion AI, paired with OncoFreeze™ AI⁸, ensures high-quality, motion-free images—eliminating the need for external gating devices. The outcome is a comprehensive imaging solution for oncology, neurology, cardiology, theranostics, and beyond.
Graphs courtesy of Siemens Healthineers
Advanced PET technology – High resolution images with new air-cooled, LSO-based digital detector. Enhanced performance and improved image quality with 239-picosecond (ps).
Advanced CT technology – Flexible 64/128 slice CT configuration. Enhanced image quality at a low dose with the Stellar detector, X-ray tube and Tin Filter.
Advanced software – Intelligent imaging tools and advanced reading solutions for multiple clinical applications.
- Oncology
- Cardiovascular
- Neurology, including Alzheimer’s disease
- Theranostics
- Stroke, including carotid CTA
- And more…………
Technical specifications—PET
| Crystal size 4 x 4 x 20 mm |
| Ultra-fast TOF performance⁴ 239 ps |
| Scalable axial field of view 18 cm, 24 cm12 |
| Effective sensitivity13 up to 128 cps/kBq14 |
| Effective peak NEC rate13 up to 1,270 kcps ≤ 25 kBq/cc14 |
| Air-cooled design |
| LSO-based digital detectors |
Technical specifications—CT
| CT slices 64/128 |
| Rotation times up to 0.33 s10 |
| Tube currents up to 825 mA |
| Maximum power 75 kW (187 kW with SAFIRE) |
| Table Weight capacity 272 kg (600 lbs) |
| Athlon™ X-ray tube |
| Tin Filter |
| Stellar detector |
The future of PET with the unparalleled performance and accessibility of the Biograph Trinion.
Contact us for more information and to reserve this exceptional Mobile PET/CT.
